Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 231 of 239
62844N406
Shares:202
Value:$288
% of Portfolio:0.0% ($288/$44.8B)
Silvaco Group, Inc.
Shares:62
Value:$283
% of Portfolio:0.0% ($283/$44.8B)
Drilling Tools International Corp
Shares:119
Value:$282
% of Portfolio:0.0% ($282/$44.8B)
Rocket Companies, Inc.
Shares:23
Value:$277
% of Portfolio:0.0% ($277/$44.8B)
CARVER BANCORP INC
Shares:188
Value:$265
% of Portfolio:0.0% ($265/$44.8B)
NORTHERN DYNASTY MINERALS LTD
Shares:232
Value:$261
% of Portfolio:0.0% ($261/$44.8B)
Finance of America Companies Inc.
Shares:12
Value:$255
% of Portfolio:0.0% ($255/$44.8B)
Tenon Medical, Inc.
Shares:120
Value:$253
% of Portfolio:0.0% ($253/$44.8B)
Verde Clean Fuels, Inc.
Shares:75
Value:$251
% of Portfolio:0.0% ($251/$44.8B)
Kezar Life Sciences, Inc.
Shares:51
Value:$249
% of Portfolio:0.0% ($249/$44.8B)
FibroBiologics, Inc.
Shares:271
Value:$244
% of Portfolio:0.0% ($244/$44.8B)
374Water Inc.
Shares:681
Value:$232
% of Portfolio:0.0% ($232/$44.8B)
Associated Capital Group, Inc.
Shares:6
Value:$230
% of Portfolio:0.0% ($230/$44.8B)
Camp4 Therapeutics Corp
Shares:57
Value:$228
% of Portfolio:0.0% ($228/$44.8B)
SOPHiA GENETICS SA
Shares:68
Value:$226
% of Portfolio:0.0% ($226/$44.8B)
Prelude Therapeutics Inc
Shares:295
Value:$226
% of Portfolio:0.0% ($226/$44.8B)
Tevogen Bio Holdings Inc.
Shares:206
Value:$222
% of Portfolio:0.0% ($222/$44.8B)
Boundless Bio, Inc.
Shares:146
Value:$220
% of Portfolio:0.0% ($220/$44.8B)
Childrens Place, Inc.
Shares:25
Value:$219
% of Portfolio:0.0% ($219/$44.8B)
Prairie Operating Co.
Shares:39
Value:$209
% of Portfolio:0.0% ($209/$44.8B)